MEK — Drug Target

All drugs that target MEK — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

MEK inhibitor

Phase 2 pipeline (1)

• ARRY-438162, MEK inhibitor; oral · Array Biopharma, now a wholly owned subsidiary of Pfizer · MEK inhibitor · Oncology
  Inhibits MEK, a protein involved in the MAPK/ERK signaling pathway, which is often dysregulated in cancer.

Phase 1 pipeline (1)

• ATR-002 MEK Inhibitor · Atriva Therapeutics GmbH · MEK inhibitor · Oncology
  MEK inhibitor